# GABAPENTIN
> **ANDA211314** · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2018-10-16
## Drug
- **FDA Application Number:** ANDA211314
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GABAPENTIN
- **Generic name:** GABAPENTIN
- **Active ingredients:** GABAPENTIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** STRIDES PHARMA
- **Manufacturer:** Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- **First approval:** 2018-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211314)
---
*AI Analytics · CC0 1.0*